Similar articles for PMID: 12788977

Year	Number of Results
1985	1
1986	1
1988	3
1989	1
1991	1
1992	2
1993	1
1994	5
1995	3
1996	2
1997	6
1998	5
1999	3
2000	11
2001	12
2002	13
2003	13
2004	12
2005	9
2006	11
2007	7
2008	9
2009	7
2010	5
2011	8
2012	8
2013	9
2014	4
2015	4
2016	8
2017	4
2018	3
2019	4
2020	2
2021	3
2022	1
2023	1
2024	0

1

Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis.

Cher ML, Biliran HR Jr, Bhagat S, Meng Y, Che M, Lockett J, Abrams J, Fridman R, Zachareas M, Sheng S. Cher ML, et al. Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7847-52. doi: 10.1073/pnas.1331360100. Epub 2003 Jun 3. Proc Natl Acad Sci U S A. 2003. PMID: 12788977 Free PMC article.

2

Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin.

Biliran H Jr, Sheng S. Biliran H Jr, et al. Cancer Res. 2001 Dec 15;61(24):8676-82. Cancer Res. 2001. PMID: 11751384

3

The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.

McGowen R, Biliran H Jr, Sager R, Sheng S. McGowen R, et al. Cancer Res. 2000 Sep 1;60(17):4771-8. Cancer Res. 2000. PMID: 10987285

4

Maspin reduces prostate cancer metastasis to bone.

Hall DC, Johnson-Pais TL, Grubbs B, Bernal R, Leach RJ, Padalecki SS. Hall DC, et al. Urol Oncol. 2008 Nov-Dec;26(6):652-8. doi: 10.1016/j.urolonc.2007.07.017. Epub 2008 Jan 15. Urol Oncol. 2008. PMID: 18367129

5

Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system.

Yin S, Lockett J, Meng Y, Biliran H Jr, Blouse GE, Li X, Reddy N, Zhao Z, Lin X, Anagli J, Cher ML, Sheng S. Yin S, et al. Cancer Res. 2006 Apr 15;66(8):4173-81. doi: 10.1158/0008-5472.CAN-05-3514. Cancer Res. 2006. PMID: 16618739

6

Maspin functions as tumor suppressor by increasing cell adhesion to extracellular matrix in prostate tumor cells.

Abraham S, Zhang W, Greenberg N, Zhang M. Abraham S, et al. J Urol. 2003 Mar;169(3):1157-61. doi: 10.1097/01.ju.0000040245.70349.37. J Urol. 2003. PMID: 12576872

7

Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model.

Shi HY, Zhang W, Liang R, Abraham S, Kittrell FS, Medina D, Zhang M. Shi HY, et al. Cancer Res. 2001 Sep 15;61(18):6945-51. Cancer Res. 2001. PMID: 11559574

8

Maspin sensitizes prostate cancer cells to doxazosin-induced apoptosis.

Tahmatzopoulos A, Sheng S, Kyprianou N. Tahmatzopoulos A, et al. Oncogene. 2005 Aug 11;24(34):5375-83. doi: 10.1038/sj.onc.1208684. Oncogene. 2005. PMID: 16007219 Free PMC article.

9

Maspin expression profile in human prostate cancer (CaP) and in vitro induction of Maspin expression by androgen ablation.

Zou Z, Zhang W, Young D, Gleave MG, Rennie P, Connell T, Connelly R, Moul J, Srivastava S, Sesterhenn I. Zou Z, et al. Clin Cancer Res. 2002 May;8(5):1172-7. Clin Cancer Res. 2002. PMID: 12006534

10

Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.

Nemeth JA, Harb JF, Barroso U Jr, He Z, Grignon DJ, Cher ML. Nemeth JA, et al. Cancer Res. 1999 Apr 15;59(8):1987-93. Cancer Res. 1999. PMID: 10213511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

189 results

Results by year